A Clinical Study of Subclinical Enthesitis and Synovitis in Patients With Vulgaris Psoriasis
- Conditions
- Vulgaris Psoriasis
- Registration Number
- NCT02339636
- Lead Sponsor
- The 306 Hospital of People's Liberation Army
- Brief Summary
A clinical study of subclinical enthesitis and synovitis in patients with vulgaris psoriasis
- Detailed Description
A total of 100 patients with vulgaris psoriasis and 100 age-matched controls with other skin diseases, all without musculoskeletal diseases, will be recruited. They will undergo dermatological assessment and a blinded PDUS evaluation. Clinical assessment included demographics, severity of psoriasis, musculoskeletal clinical examination and sport activities. PDUS evaluation consisted of the detection of grey scale (GS) synovitis and synovial PD signal in joints of extremities, GS enthesopathy and entheseal PD signal in entheses of lower limbs.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
- age≥18years
- patients with vulgaris psoriasis(dur
- patients with other skin diseases without musculoskeletal disorders
- no joint involvement and no clinical symptoms and signs of enthesitis and synovitis
- BMI≥24
- have history of gout or arthritis or peripheral neurological disease of lower extremity or trauma
- have received any systemic therapy(i.e.NSAIDs, corticosteroids, immunosuppressants, retinoids or biological agents) in 3 months
- pregnant or breast-feeding
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of subclinical enthesitis and synovitis one and a half year To investigate the incidence of subclinical enthesitis and synovitis in patients with vulgaris
- Secondary Outcome Measures
Name Time Method Number of participants with Risk factors of subclinical enthesitis and synovitis one and a half year To find out predictor factors of subclinical enthesitis and synovitis in patients with vulgaris psoriasis
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
306 Hospital of PLA
🇨🇳Beijing, China
306 Hospital of PLA🇨🇳Beijing, Chinajianjun liu, MDContactliujianjun306@126.com
